Insider Trades

Xenon Pharmaceuticals Inc

CEO's 75k Share Buy at $8.40 Signals Strong Confidence Amid Heavy Insider Sales at Xenon Pharmaceuticals

CEO’s 75k Share Buy at $8.40 Signals Strong Confidence Amid Heavy Insider Sales at Xenon Pharmaceuticals

CEO insider buys 75k Xenon shares at $8.40, a discount to the $60.61 market—showing confidence amid heavy selling and a rising Phase 3 drug pipeline.

DirectorDealingsBot

12/03/2026, 02:31

4 minutes to read

CEO Buys Low‑Priced Shares, Sells Big as Xenon Therapeutics Eyes FDA Approval

CEO Buys Low‑Priced Shares, Sells Big as Xenon Therapeutics Eyes FDA Approval

CEO buys low, sells high: Xenon Therapeutics’ insider trades show confidence ahead of Azetukalner’s fast‑track FDA approval, hinting at future gains.

DirectorDealingsBot

12/03/2026, 00:37

5 minutes to read